MiniMed Group Inc.
MMED | NASDAQ
$18.28
-$0.97 (-5.04%)
At close: Oct 30, 2026, 4:00 PM ET
$18.20
-$0.08 (-0.44%)
Pre-market:
Nov 2, 2026, 9:05 AM ET
TTM Period Ending | Q1 2026 Jul 31, 2026 | Q4 2025 Apr 24, 2026 | Q3 2025 Jan 31, 2026 | Q2 2025 Oct 31, 2025 | Q4 2024 Apr 30, 2025 |
|---|---|---|---|---|---|
Revenue | 3.22B | 2.38B | 2.27B | 1.48B | 724M |
Cost of Revenue | 1.49B | 1.11B | 1.07B | 645M | 321M |
Gross Profit | 1.74B | 1.27B | 1.19B | 830M | 402M |
Operating Income | 17M | -21M | -307M | -214M | -204M |
Interest Income | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -197M | -201M | -315M | -216M | -204M |
Net Income | -329M | -329M | -355M | -236M | -209M |
Selling & General & Admin | 1.24B | 926M | 954M | 645M | 327M |
Research & Development | 439M | 324M | 334M | 220M | 109M |
Other Expenses | 41M | 41M | 212M | 180M | 171M |
Operating Expenses | 1.72B | 1.29B | 1.5B | 1.05B | 607M |
Interest Expense | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 309M | 309M | 636M | 327M | 327M |
Cost & Expenses | 3.21B | 2.4B | 2.57B | 1.69B | 928M |
Income Tax Expense | 128M | 124M | 48M | 36M | 17M |
Shares Outstanding (Basic) | 281M | 268.1M | 280.81M | n/a | n/a |
Shares Outstanding (Diluted) | 281M | 268.1M | 280.81M | n/a | n/a |
EPS (Basic) | -1.10 | -1.10 | -0.42 | n/a | n/a |
EPS (Diluted) | -1.10 | -1.10 | -0.42 | n/a | n/a |
EBITDA | 89M | 51M | -31M | 29M | n/a |
EBIT | 11M | -27M | -147M | -48M | -38M |
Depreciation & Amortization | 78M | 78M | 116M | 77M | 38M |
Add to Watchlist
Select watchlists to add or remove MMED